LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Apogee Therapeutics Q2 Loss After Taxes $66.1 Mln Vs Loss $33.8 Mln Last Year 8/11/2025 7:51:47 AM
  • Wedbush Reiterates Apogee Therapeutics, Inc. (APGE) At Outperform With $90 Price Target 7/7/2025 12:39:32 PM
  • Apogee Therapeutics Announces Positive 16-week Data From Part A Of Phase 2 APEX Clinical Trial Of APG777 7/7/2025 6:03:19 AM
  • Apogee Therapeutics Q1 Net Loss $55.3 Mln Vs Loss $32.1 Mln Last Year 5/12/2025 6:11:59 AM
  • Apogee Therapeutics Announces Positive Interim Results From Phase 1b Trial Of APG808 In Mild-to-Moderate Asthma 5/12/2025 6:04:52 AM
  • Wedbush Reiterates Apogee Therapeutics, Inc. (APGE) At Outperform With $90 Price Target 3/11/2025 11:18:38 AM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) FY25 Estimate To -4.92 From -3.93 3/3/2025 10:26:16 AM
  • Wedbush Is Cutting Apogee Therapeutics, Inc. (APGE) Q4 25 Estimate To -1.21 From -0.97 3/3/2025 10:26:05 AM
  • Wedbush Is Cutting Apogee Therapeutics, Inc. (APGE) Q3 25 Estimate To -1.21 From -0.97 3/3/2025 10:25:49 AM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) Q2 25 Estimate To -1.26 From -1.01 3/3/2025 10:25:16 AM
  • Wedbush Is Cutting Apogee Therapeutics, Inc. (APGE) Q1 25 Estimate To -1.24 From -0.99 3/3/2025 10:25:03 AM
  • Wedbush Reiterates Apogee Therapeutics, Inc. (APGE) At Outperform With $90 Price Target 3/3/2025 10:24:40 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap